Section 721.10416 - Brominated polyphenyl ether (generic) (P-11-264)(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified generically as brominated polyphenyl ether (PMN P-11-264) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance after it has been completely reacted (cured).(2) The significant new uses are:(i)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(j) (manufacture of the substance at a molecular weight greater than or equal to that described in PMN P-11-264), § 721.80 (k) (manufacture at the facility described in PMN P-11-264 or by the process described in PMN P-11-264 (changes in manufacturing processes include, but are not limited to, changes in feedstock, reaction conditions, and/or product isolation and purification) unless the brominated dibenzodioxin (BDD)/brominated dibenzofuran (BDF) testing (EPA Test Method 8290A) required in the consent order is conducted at the new facility or for the new manufacturing method and the test results submitted to EPA within 16 months of changing the manufacturing process or commencement of manufacture at a different facility; manufacture of the substance where levels of the fifteen BDD/BDF congeners are detected at or below the Levels of Quantification (LOQs) published in EPA's Dioxin test rule (40 CFR 766.27 )).(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1)Recordkeeping. Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section. 77 FR 24626 , Apr. 25, 2012